SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense investor volatility following a quarterly earnings report that featured massive revenue and earnings beats alongside an expanded share buyback program. While bulls point to record margins and long-term AI-driven demand as evidence of undervaluation, the stock has experienced significant after-hours swings as participants debate whether near-term growth is plateauing relative to aggressive market expectations.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is generating intense community interest ahead of its upcoming earnings report, with bulls anticipating a short squeeze driven by significant short interest and potential momentum from its OASYS growth engine. Investors are closely debating the company's path to profitability while speculating whether strong enterprise adoption and the pending LivePerson acquisition will serve as the catalysts to drive the stock higher.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are trending due to a sharp rebound following an initial sell-off sparked by a minor revenue miss and cautious Q3 guidance, with investors debating whether the volatility is an overreaction to the company's strong margins and AI-driven growth or a sign of unsustainable valuations. The community is actively discussing the stock's massive recovery off its lows, the resolution of an SEC inquiry, and conflicting perspectives on whether this dip represents a prime buying opportunity or the beginning of a larger correction in the software sector.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending as investors show renewed interest ahead of the company's Q2 earnings report, driven by a solid backlog and recent selection for a major U.S. Space Force contract. The community is actively debating the company's long-term valuation compared to sector peers and monitoring potential institutional accumulation following recent filings.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to final regulatory approval of its SkyWater Technology acquisition, a strategic move that significantly bolsters its manufacturing capabilities and supply chain. Investors are actively debating the long-term potential of this vertical integration against near-term concerns regarding shareholder dilution and the company's path toward scalable fault-tolerant quantum computing.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is currently facing intense volatility and downward pressure as investors closely monitor execution concerns and margin pressures ahead of upcoming earnings. While the community is debating whether the current sell-off is an overreaction to temporary accounting delays or a reflection of structural challenges, many are looking for concrete updates on hyperscaler purchase orders to validate the company's long-term backlog and AI infrastructure thesis.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing extreme volatility and intense community debate as investors weigh strong quarterly earnings and AI-driven growth against significant short interest and lock-up expiration concerns. While bulls are highlighting the company's expanding enterprise dominance and sustained adoption of AI features, a vocal bearish contingent remains skeptical of its valuation and points to historical insider selling as a potential headwind for the stock's recovery.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are facing significant volatility as investors weigh strong earnings beats and ongoing enterprise data demand against softer guidance and broader sector-wide profit-taking. The community remains deeply divided, with many traders debating whether the stock is being unfairly manipulated by institutional algorithms or if the memory cycle has reached its peak.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a new strategic partnership with Travis Kalanick's Atoms to develop U.S. vertiport infrastructure, while the community intensely debates the company's progress toward FAA type certification and upcoming H2 2026 commercial milestones. While some traders are focused on short-term volatility and potential short-squeeze dynamics, many others are emphasizing the long-term potential of the firm's partnerships with Toyota, Delta, and Uber as proof of its leadership in the nascent urban air mobility sector.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is currently experiencing high volatility driven by a significant short interest that has sparked intense community debate over potential short squeeze scenarios versus structural debt concerns. The stock remains a focal point for investors speculating on upcoming biodefense contracts, particularly as sentiment fluctuates around recent government health procurement narratives and the company's efforts to navigate shifting industry demands.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of +6.50% and +3.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?

Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care

OCGN is advancing gene-agnostic eye therapies across retinal diseases, with key trial data and regulatory milestones approaching in 2026 and 2027.

Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?

Ocugen faces cash burn and dilution risks, but upcoming eye gene therapy data and planned filings through 2027 could shape its next phase.

OCGN's Catalyst Calendar for Trial Data and Filings Through 2028

Ocugen's three ocular gene therapy programs could deliver trial data, filings, and potential BLA milestones through 2028 as key readouts approach.

Ocugen (OCGN) Upgraded to Buy: Here's Why

Ocugen (OCGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

Ocugen swings to a wider Q1 loss as costs climb, but pipeline milestones and gene therapy data keep its long-term plans on track.

Ocugen, Inc. (NASDAQ:OCGN) Given Average Recommendation of "Moderate Buy" by Brokerages

Ocugen, Inc. (NASDAQ:OCGN - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the five research firms that are presently covering the company, MarketBeat Ratings reports...

Ocugen Q1 Earnings Call Highlights

Ocugen (NASDAQ:OCGN) used its first-quarter 2026 earnings call to highlight progress across its retinal gene therapy pipeline and to outline a strengthened balance sheet following a newly announced...

Ocugen (NASDAQ:OCGN) Issues Earnings Results, Misses Expectations By $0.01 EPS

Ocugen (NASDAQ:OCGN - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.01). Ocugen had a negative return on equity of 2,626.38% and a negative net margin of 1,192.18...

This account has been verified as an official OCGN representative.

Verified Account

Ocugen

$OCGN Q1 '26 Earnings Results & Recap

Ocugen expects its cash runway to extend into 2028 following the closing of a $115 million private offering of 6.75% convertible senior notes, subject to customary closing conditions.

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Ocugen Inc

OCGN Stock Tanks After Gene Therapy Trial Update — What Did Ocugen Announce?

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.05	--	--	N/A
Q1 '26	-$0.05	-$0.06	-16.67%	MISSED
Q4 '25	-$0.06	-$0.06	-2.65%	MISSED
Q3 '25	-$0.06	-$0.07	-25.00%	MISSED
Q2 '25	-$0.06	-$0.05	10.71%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings